BPA Call 36C24820A0022-36C24820N0622
Award Date 6/4/20
Potential Completion Date 9/30/20
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
KNG OF PRUSSA, PA 19406, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a foreign-owned, for-profit biotherapeutics company. The contract is for the supply of 5 gram vials of the immune globulin drug Privigen. The BPA call has a ceiling value of $84,903.00 and was awarded under CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which has a total ceiling value of...
- The Department of Veterans Affairs Veterans Health Administration awarded a $20 million firm fixed price blanket purchase agreement call against CSL Behring L.L.C.'s GSA Pharmaceuticals and Drugs schedule. CSL Behring will deliver a special order of Privigen to multiple VA medical centers in Veterans Integrated Service Network 8. Performance will take place in Orlando, Florida over a nine month period concluding in September 2020. This non-set aside award supports the VA's mission to provide...
- CSL Behring L.L.C. was awarded a blanket purchase agreement (BPA) call against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8. The BPA call is for the purchase of Privigen across VISN 8 facilities located in Gainesville, Florida, and has a potential value of $136,441.88 to be paid on a firm fixed price basis. No set-aside designation was applied to this contract award. The BPA was...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call under a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to CSL Behring L.L.C., a foreign-owned, for-profit organization specializing in plasma-derived and recombinant therapies. The contract award, valued at $84,903.00, is for the supply of 44206-0436-05 5GM GLOBULINE, IMMUNE PRIVIGEN, a pharmaceutical product, to support healthcare services for veterans. CSL Behring holds several...
- CSL Behring L.L.C. was awarded a firm fixed-price blanket purchase agreement (BPA) call contract valued at one hundred thirty-six thousand four hundred forty-one dollars and eighty-eight cents ($136,441.88) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8. The contract calls for delivery of the pharmaceutical Privigen under the Pharmaceuticals and Drugs Federal Supply Schedule master contract. Performance will occur in Gainesville,...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded CSL Behring L.L.C. a blanket purchase agreement (BPA) call against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master contract. The BPA call has a potential value of $25,213.77 and requires delivery of unspecified pharmaceutical or drug products to locations in King of Prussia, Pennsylvania under firm fixed price terms by April 30, 2020. No set-aside designation...
- This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a global biotherapeutics company, for the supply of PRIVIGEN GLOBULIN, IMMUNE. The contract is a Blanket Purchase Agreement (BPA) Call under the VA's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract has a ceiling value of $84,601.40 and is for a firm fixed price. The contract was awarded on November 1, 2019, with a completion date of November...
- This federal contract award is for the procurement of pharmaceutical products, specifically immune globulin medications, by the U.S. Department of Veterans Affairs (VA). The contract was awarded to CSL Behring L.L.C., a global biotherapeutics company, under the VA's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract has a ceiling value of $102,089.00 and is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type. The contract is...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VHA VISN 8) awarded CSL Behring L.L.C. a $117,050.64 potential value blanket purchase agreement (BPA) call against the Pharmaceuticals and Drugs Government-Wide Acquisition Contract (FSS-61-IB). The BPA, described as a VISN WIDE BPA with no set-aside designation, is for the delivery of pharmaceutical products and has a completion date of August 20, 2020. Performance will take place in King of...
- This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to CSL Behring LLC, a global biotherapeutics company, for the emergency purchase of Privigen, an intravenous immunoglobulin product, in various dosage sizes. The award was made against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the VA and General Services Administration (GSA), which allows the VA and other agencies to efficiently procure...